Broad spectrum monoclonal antibody-based therapeutic for botulism

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Project Description:
This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.
 
Project Terms:
advanced development base biodefense botulinum botulism clinical development monoclonal antibodies pre-clinical product development research and development support contracts therapeutic translational research biotechnology emerging infectious diseases food safety infectious diseases rare diseases
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Project Categories:
Natural Sciences > Clinical Trials & Therapy > Clinical trials
 
Other Information:
Fiscal Year: 2011
Project Start Date: 30 September 2011
Project End Date: 30 September 2016
 
Project Funding Information:
Funding Mechanism: Non SBIR/STTR Contracts
Year Funding Organization Total Funding, $
2014 NIH - National Institute Of Allergy And Infectious Diseases $10,911,958
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Title FY Funding
There are no results for this project in database.
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Project Title Organization FY Funding
Broad Spectrum Monoclonal Antibody-Based Therapeutic For BotulismXoma Corporation2014$10,911,958
Broad Spectrum Monoclonal Antibody-Based Therapeutic For BotulismXoma Corporation2013$5,969,753
Monoclonal Antibody-Based Therapeutics For BotulismXoma Corporation2012$15,013,143
Development Of Monoclonal Antibody-Based Therapeutics For BotulismXoma Corporation2012$2,157,123
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Broad spectrum monoclonal antibody-based therapeutic for botulism
Project Number: 272201100031C-4-0-1
Project web address: Follow on NIH
Organization: Xoma Corporation, United States, California, BERKELEY
Principal Investigators (PI): Tomic Milan, US
 
Title Journal Year Country Rel